WallStreetZenWallStreetZen

NASDAQ: APYX
Apyx Medical Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for APYX

Based on 3 analysts offering 12 month price targets for Apyx Medical Corp.
Min Forecast
$4.50+39.75%
Avg Forecast
$7.17+122.58%
Max Forecast
$9.00+179.5%

Should I buy or sell APYX stock?

Based on 3 analysts offering ratings for Apyx Medical Corp.
Strong Buy
Strong Buy
3 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their APYX stock forecasts and price targets.

APYX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Piper Sandler
Bottom 3%
3
Strong BuyMaintains$4.50+39.75%2023-08-11
Stephens & Co.
Bottom 11%
11
Strong BuyInitiates Coverage On$8.00+148.45%2023-07-14
Lake Street
Bottom 7%
7
Strong BuyMaintains$9.00+179.50%2023-06-15

1 of 1

Forecast return on equity

Is APYX forecast to generate an efficient return?
Company
-32.19%
Industry
22.67%
Market
58.62%
APYX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is APYX forecast to generate an efficient return on assets?
Company
-18.87%
Industry
11.73%
APYX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

APYX revenue growth forecast

How is APYX forecast to perform vs Medical Devices companies and vs the US market?
Company
23.27%
Industry
6.71%
Market
7.9%
APYX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
APYX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

APYX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
APYX$3.22$7.17+122.58%Strong Buy
INGN$5.21$14.00+168.71%Hold
CLPT$5.14$15.00+191.83%Strong Buy
ELMD$10.75$15.00+39.53%Strong Buy
RBOT$0.71$9.00+1,169.39%Strong Buy
View Top Medical Device Stocks

Apyx Medical Stock Forecast FAQ

Is Apyx Medical Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: APYX) stock is to Strong Buy APYX stock.

Out of 3 analysts, 3 (100%) are recommending APYX as a Strong Buy, 0 (0%) are recommending APYX as a Buy, 0 (0%) are recommending APYX as a Hold, 0 (0%) are recommending APYX as a Sell, and 0 (0%) are recommending APYX as a Strong Sell.

If you're new to stock investing, here's how to buy Apyx Medical stock.

What is APYX's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: APYX) forecast ROE is -32.19%, which is considered weak.

What is APYX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year APYX price target, the average APYX price target is $7.17, with the highest APYX stock price forecast at $9.00 and the lowest APYX stock price forecast at $4.50.

On average, Wall Street analysts predict that Apyx Medical's share price could reach $7.17 by Aug 11, 2024. The average Apyx Medical stock price prediction forecasts a potential upside of 122.58% from the current APYX share price of $3.22.

What is APYX's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: APYX) forecast ROA is -18.87%, which is lower than the forecast US Medical Devices industry average of 11.73%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.